Organosyn lifesciences ltd

- Treatment of duodenal ulcer. - Prevention of recurrence of duodenal ulcer. - Treatment of gastric ulcer. - Prevention of recurrence of gastric ulcer. - In combination with appropriate antibiotics for the eradication of Helicobacter pylori (H. Pylori) associated with peptic ulcer. - Treatment of gastric and duodenal ulcers associated with intake of non-steroidal anti-inflammatory drugs (NSAIDs). - Prevention of gastric and duodenal ulcers associated with the administration of NSAIDs in at-risk patients. - Treatment of reflux esophagitis. - Supportive therapy in patients after treatment of reflux esophagitis. - Symptomatic treatment of gastroesophageal reflux disease (GERD). - Treatment of Zollinger-Ellison  syndrome.  

Treatment of mixed infections caused by pathogens (microorganisms and protozoa): - diseases of the genitourinary system: acute and chronic pyelonephritis, prostatitis, cystitis, epididymitis, complicated or recurrent urinary tract infections; - sexually transmitted diseases.